Episode description
Episode description
Gil Blander is the founder and Chief Science Officer of InsideTracker, a personalized nutrition company that helps people live better and longer. Inside Tracker takes a unique approach to personalized wellness by analyzing blood biomarkers, DNA, and fitness tracker data to provide actionable recommendations on food, supplements, exercise, and lifestyle changes.
Blander is an Israeli scientist and PhD from the Weizman Institute of Science who moved to Cambridge, Massachusetts to perform a postdoctoral fellowship at MIT. He was inspired by his supervisor and fellow postdoctoral fellow, David Sinclair, to start Inside Tracker which now holds a valuation of over $100,000,000.Highlights from our conversation:
- What is Inside Tracker & How does it work?
- Aging Research and the Biotech/Pharmaceutical Industry Trends
- Raising Capital for a Longevity and Nutrition Startup
- Lessons Learned from Inside Tracker's Early Stages
- Reflections on Allocating Capital for a Startup
- Raising Funds and Growing a Platform: Advice from a Startup Founder"
- Benefits of Personalized Wellness
- Benefits of Longevity Medicine for Primary Care Patients
- The Future of Healthcare: Integrating Food Recognition Platforms for Improved Nutritional Habits
More from Gil:
More from Delaney: